Kamada Signs Deal To Supply Israel’s Health Ministry With COVID-19 Antibody Drug
Kamada developed a plasma-derived, investigational antibody treatment for COVID-19 currently under trial; interim results show promise.
October 19, 2020
New Antibody Cocktail May Provide COVID-19 Immunity For Months, Say Israeli Scientists
A team of Israeli researchers have isolated six antibodies that work in combination to target the coronavirus and neutralize it.
October 11, 2020
Early Results For COVID-19 Trial With Antibody Drug Show 90% Improvement Rate
The trial involves 12 hospitalized but non-ventilated COVID-19 patients with pneumonia; 11 of them have been discharged, Kamada says.
September 09, 2020
Severely Ill COVID-19 Patients Produce Antibodies Faster, Israeli Study Finds
Researchers from TAU believe the study has important implications for understanding a patient's immune response to the SARS-CoV-2.
July 08, 2020
